These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 12868251

  • 1. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial.
    Lappin MS, Lawrie FW, Richards TL, Kramer ED.
    Altern Ther Health Med; 2003; 9(4):38-48. PubMed ID: 12868251
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis.
    Haase R, Piatkowski J, Ziemssen T.
    Altern Ther Health Med; 2011; 17(6):22-8. PubMed ID: 22314716
    [Abstract] [Full Text] [Related]

  • 3. Reflexology for the treatment of pain in people with multiple sclerosis: a double-blind randomised sham-controlled clinical trial.
    Hughes CM, Smyth S, Lowe-Strong AS.
    Mult Scler; 2009 Nov; 15(11):1329-38. PubMed ID: 19825891
    [Abstract] [Full Text] [Related]

  • 4. A randomized placebo-controlled cross-over study using a low frequency magnetic field in the treatment of fatigue in multiple sclerosis.
    de Carvalho ML, Motta R, Konrad G, Battaglia MA, Brichetto G.
    Mult Scler; 2012 Jan; 18(1):82-9. PubMed ID: 21788248
    [Abstract] [Full Text] [Related]

  • 5. Low-amplitude, extremely low frequency magnetic fields for the treatment of osteoarthritic knees: a double-blind clinical study.
    Jacobson JI, Gorman R, Yamanashi WS, Saxena BB, Clayton L.
    Altern Ther Health Med; 2001 Jan; 7(5):54-64, 66-9. PubMed ID: 11565402
    [Abstract] [Full Text] [Related]

  • 6. Managing the symptoms of multiple sclerosis: a multimodal approach.
    Crayton HJ, Rossman HS.
    Clin Ther; 2006 Apr; 28(4):445-60. PubMed ID: 16750459
    [Abstract] [Full Text] [Related]

  • 7. Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity.
    Goodkin DE, Rudick RA, VanderBrug Medendorp S, Greene T, Schwetz KM, Fischer J, Daughtry MM, Ross J, Van Dyke C.
    Online J Curr Clin Trials; 1992 Sep 25; Doc No 19():[7723 words; 89 paragraphs]. PubMed ID: 1343611
    [Abstract] [Full Text] [Related]

  • 8. Impact of low frequency pulsed magnetic fields on pain intensity, quality of life and sleep disturbances in patients with painful diabetic polyneuropathy.
    Wróbel MP, Szymborska-Kajanek A, Wystrychowski G, Biniszkiewicz T, Sieroń-Stołtny K, Sieroń A, Pierzchała K, Grzeszczak W, Strojek K.
    Diabetes Metab; 2008 Sep 25; 34(4 Pt 1):349-54. PubMed ID: 18585071
    [Abstract] [Full Text] [Related]

  • 9. Pilot crossover trial of Reiki versus rest for treating cancer-related fatigue.
    Tsang KL, Carlson LE, Olson K.
    Integr Cancer Ther; 2007 Mar 25; 6(1):25-35. PubMed ID: 17351024
    [Abstract] [Full Text] [Related]

  • 10. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M, Onesti E, Tomassini V, Conte A, Gupta S, Gilio F, Pantano P, Pozzilli C, Inghilleri M.
    Clin Neuropharmacol; 2009 Mar 25; 32(1):41-7. PubMed ID: 18978501
    [Abstract] [Full Text] [Related]

  • 11. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Mar 25; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 12. Prospective, randomized, single-blind, sham treatment-controlled study of the safety and efficacy of an electromagnetic field device for the treatment of chronic low back pain: a pilot study.
    Harden RN, Remble TA, Houle TT, Long JF, Markov MS, Gallizzi MA.
    Pain Pract; 2007 Sep 25; 7(3):248-55. PubMed ID: 17714104
    [Abstract] [Full Text] [Related]

  • 13. Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis--a double blind, placebo controlled, randomised clinical trial.
    McClurg D, Ashe RG, Lowe-Strong AS.
    Neurourol Urodyn; 2008 Sep 25; 27(3):231-7. PubMed ID: 17705160
    [Abstract] [Full Text] [Related]

  • 14. Low-frequency pulsed electromagnetic field therapy in fibromyalgia: a randomized, double-blind, sham-controlled clinical study.
    Sutbeyaz ST, Sezer N, Koseoglu F, Kibar S.
    Clin J Pain; 2009 Oct 25; 25(8):722-8. PubMed ID: 19920724
    [Abstract] [Full Text] [Related]

  • 15. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, Louis ED, Mulligan T, Foster PS, Shenal BV, Armaghani SJ, Jacobson C, Wu S, Crucian G.
    Arch Neurol; 2006 May 25; 63(5):729-35. PubMed ID: 16682542
    [Abstract] [Full Text] [Related]

  • 16. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M, French Modafinil Study Group.
    Neurology; 2005 Apr 12; 64(7):1139-43. PubMed ID: 15824337
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C.
    J Neurol Sci; 2004 Mar 15; 218(1-2):103-8. PubMed ID: 14759641
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis.
    Breuer B, Pappagallo M, Knotkova H, Guleyupoglu N, Wallenstein S, Portenoy RK.
    Clin Ther; 2007 Sep 15; 29(9):2022-30. PubMed ID: 18035201
    [Abstract] [Full Text] [Related]

  • 19. Long-term benefits of exercising on quality of life and fatigue in multiple sclerosis patients with mild disability: a pilot study.
    McCullagh R, Fitzgerald AP, Murphy RP, Cooke G.
    Clin Rehabil; 2008 Mar 15; 22(3):206-14. PubMed ID: 18285430
    [Abstract] [Full Text] [Related]

  • 20. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.
    Kelleher CJ, Cardozo L, Chapple CR, Haab F, Ridder AM.
    BJU Int; 2005 Jan 15; 95(1):81-5. PubMed ID: 15638900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.